HEDIS® Results
Medicaid HEDIS® Annual Rates.
Molina’s scores for the past two years are below. You can see how Molina performs compared to our target goal.
Measure |
2021 |
2022 |
Goal |
Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA) |
72.98% |
64.13% |
64.52% |
Annual Dental Visits (ADV) Total |
NB |
NB |
53.67% |
Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment |
36.07% |
32.40% |
46.09% |
Appropriate Testing for Pharyngitis (CWP) |
82.47% |
71.59% |
74.02% |
Appropriate Treatment for Upper Respiratory Infection (URI) |
85.39% |
88.16% |
92.46% |
Asthma Medication Ratio (AMR) Total |
64.50% |
63.15% |
68.21% |
Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB) |
47.72% |
50.11% |
58.74% |
Breast Cancer Screening (BCS) |
57.64% |
53.25% |
53.96% |
Cervical Cancer Screening (CCS) |
58.15% |
62.53% |
60.83% |
Childhood Immunization Status (CIS) Combination #10 |
32.12% |
25.79% |
39.42% |
Chlamydia Screening in Women (CHL) Total |
59.16% |
57.78% |
60.24% |
Comprehensive Diabetes Care (CDC) BP Control <140/90 |
60.34% |
64.72% |
65.21% |
Comprehensive Diabetes Care (CDC) HbA1c Control <8.0% |
44.77% |
46.23% |
52.80% |
Comprehensive Diabetes Care (CDC) Eye Exam |
55.96% |
56.45% |
54.74% |
Controlling High Blood Pressure (CBP) |
47.45% |
54.74% |
63.50% |
Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) |
74.31% |
79.97% |
81.21% |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total |
11.59% |
11.23% |
16.16% |
Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total |
38.55% |
42.06% |
45.35% |
Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total |
39.70% |
37.88% |
42.75% |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total |
28.96% |
25.19% |
37.86% |
Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase |
66.34% |
45.50% |
55.40% |
Immunizations for Adolescents (IMA) Combination #2 |
32.60% |
28.95% |
39.16% |
Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Rate Total |
11.54% |
11.92% |
16.57% |
Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Total |
25.98% |
26.94% |
39.29% |
Pharmacotherapy for Opioid Use Disorder (POD) Total |
24.28% |
52.43% |
33.15% |
Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids |
70.38% |
68.87% |
74.76% |
Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator |
82.88% |
79.47% |
87.83% |
Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years |
92.12% |
89.25% |
≤ 94.44% |
Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care |
92.70% |
87.83% |
87.83% |
Prenatal and Postpartum Care (PPC) Postpartum Care |
74.45% |
75.67% |
80.00% |
Prenatal Immunization Status (PRS) Combination Rate |
18.37% |
13.89% |
27.32% |
Risk of Continued Opioid Use (COU) 31-Day Total |
3.45% |
2.83% |
≤ 2.35% |
Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total |
80.70% |
82.32% |
82.29% |
Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total |
67.06% |
59.68% |
73.75% |
Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy |
66.72% |
66.58% |
68.32% |
Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80% |
63.48% |
55.51% |
70.00% |
Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total |
60.43% |
54.50% |
65.63% |
Use of Imaging Studies for Low Back Pain (LBP) |
68.74% |
68.69% |
76.82% |
Use of Opioids at High Dosage (HDO) |
2.69% |
1.93% |
≤ 2.65% |
Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies |
2.04% |
1.16% |
≤ 0.90% |
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile |
73.24% |
70.56% |
82.73% |
NA = Not Available Due to Small Denominator
NB = No Benefit
NR = Not Reported
NQ = Not Required
BR = Biased Rate